Darbepoetin for the treatment of anemia of myelodysplastic syndromes: efficacy and quality of life

被引：0
|
作者：
Oliva, E. N.
Latagliata, R.
Danova, M.
Specchia, G.
Impera, S.
Rovati, B.
Vincelli, I.
Liso, V.
Alimena, G.
Ronco, F.
Carmosino, I.
Risitano, A.
Breccia, M.
Nobile, F.
机构：
[1] Hematol Unit, Az Osp BMM Reggio Calabria, Calabria, Italy
[2] Univ Roma La Sapienza, Dept Hematol, Rome, Italy
[3] Univ S Matteo, Cytometry & Cellular Therapies Unit, Pavia, Italy
[4] Studi Bari Univ, Cattedra Serv Ematol, Bari, Italy
[5] Az Osp, Oncohematol Unit, Catania, Italy
[6] Univ Naples Federico II, Inst Hematol, Naples, Italy
来源：
LEUKEMIA RESEARCH | 2007年 / 31卷
关键词：
D O I：
10.1016/S0145-2126(07)70212-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S117 / S118
页数：2
相关论文
共 50 条
  • [31] Combination of erythropoietin and thalidomide for the treatment of anemia in patients with myelodysplastic syndromes
    Musto, P
    Falcone, A
    Sanpaolo, G
    Bodenizza, C
    LEUKEMIA RESEARCH, 2006, 30 (04) : 385 - 388
  • [32] The Importance of Quality of Life for Patients Living With Myelodysplastic Syndromes
    Thomas, Mary Laudon
    Crisp, Nicole
    Campbell, Karen
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2012, 16 (03) : 47 - 57
  • [33] Quality of life and psychosocial adjustment in patients with myelodysplastic syndromes
    Thomas, ML
    LEUKEMIA RESEARCH, 1998, 22 : S41 - S47
  • [34] Quality of Life in Myelodysplastic Syndromes and Physicians' Perception.
    Oliva, Esther Natalie
    Santini, Valeria
    Antonella, Poloni
    Liso, Vincenzo
    Cilloni, Daniela
    Terenzi, Adelmo
    Guglielmo, Patrizia
    Ghio, Riccardo
    Cortelezzi, Agostino
    Semenzato, Giampietro
    Clissa, Cristina
    Salvi, Flavia
    Villani, Oreste
    Spiriti, Maria Antonietta Aloe
    BLOOD, 2009, 114 (22) : 1470 - 1471
  • [35] An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes
    Garcia, Jacqueline S.
    Jain, Nitin
    Godley, Lucy A.
    ONCOTARGETS AND THERAPY, 2010, 3 : 1 - 13
  • [36] Azacitidine: activity and efficacy as an epigenetic treatment of myelodysplastic syndromes
    Santini, Valeria
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (02) : 121 - 127
  • [37] Anemia as the Main Manifestation of Myelodysplastic Syndromes
    Santini, Valeria
    SEMINARS IN HEMATOLOGY, 2015, 52 (04) : 348 - 356
  • [38] Prognostic relevance of anemia in myelodysplastic syndromes
    Cazzola, Mario
    Malcovati, Luca
    AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (10) : 761 - 762
  • [39] Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic review
    Mo, Allison
    Poynton, Matthew
    Wood, Erica
    Shortt, Jake
    Brunskill, Susan J.
    Doree, Carolyn
    Sandercock, Josie
    Saadah, Nicholas
    Luk, Edwin
    Stanworth, Simon J.
    Mcquilten, Zoe
    BLOOD REVIEWS, 2023, 61
  • [40] Lower-risk myelodysplastic syndromes: Current treatment options for anemia
    Meunier, Mathieu
    Park, Sophie
    EJHAEM, 2022, 3 (04): : 1091 - 1099
12345